Company:
AlloCureInvestor(s):
SV Life SciencesInvestor(s):
Novo A/SType of Financing:
Venture Capital - Series AClose Date:
2008-07-02Capital Raised:
$14,500,000 USDDeal Description:
AlloCure Inc, a biotechnology company, today announced the closing of a $ 14.5MM Series A financing. The round was led by SV Life Sciences with Novo A/S joining the syndicate. The funding will be used to advance groundbreaking treatments and entering clinical trials.